Search
for
Sort by
Research 91–120 of 1000+
- Finasteride drug safety alert
- Scientific Opinion on the safety of “coriander seed oil” as a Novel Food ingredient
- Taking advantage from phenotype variability in a local animal genetic resource: identification of genomic regions associated with the hairless phenotype in Casertana pigs
- The Tumor Suppressor Actions of the Vitamin D Receptor in Skin
- Scientific Opinion on the substantiation of health claims related to spermidine and contribution to normal hair growth (ID 1705) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
- Scientific Opinion on the substantiation of a health claim related to spermidine and prolongation of the growing phase (anagen) of the hair cycle pursuant to Article 13(5) of Regulation (EC) No 1924/2006
- Effects of Finasteride and DEHP on anogenital distance and nipple retention after perinatal exposure in rats
- Photo-responsive fibers as artificial hairs in an in-vitro model for transdermal drug delivery
- Anogenital distance as a biomarker for incomplete masculinization : Molecular mechanisms in the perineum
- Phase I Clinical Testing Antimalarial Drugs.
- Cutaneous signs in COVID ‐19 patients: A review
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- The impact of air pollution on skin and related disorders: A comprehensive review
- Tofacitinib for the treatment of lichen planopilaris: A case series
- COVID‐19 with dermatologic manifestations and implications: An unfolding conundrum
- Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation
- Multi-therapies in androgenetic alopecia: review and clinical experiences
- Dermatological medication effects on male fertility
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti‐androgens
- Telogen effluvium associated with COVID‐19 infection
- Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID ‐19 pandemic
- Clinical utility and validity of minoxidil response testing in androgenetic alopecia
- Evaluation of the effects of COVID‐19 pandemic on hair diseases through a web‐based questionnaire
- Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study
- Treatment of telogen effluvium using a dietary supplement containing <i>Boswellia serrata</i> , <i>Curcuma longa</i> , and <i>Vitis vinifera</i> : Results of an observational study
- Cyclosporin in dermatology: A practical compendium
- Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C’s of oral therapy
- Effect of different types of therapeutic trauma on vitiligo lesions
- Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience